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Cognitive impairment in bipolar disorder 
Neuroprogression or behavioral variant frontotemporal dementia?
Saulo Queiroz Borges1 , Thiago Xavier Corrêa1 , Isabela Oliveira Azevedo Trindade2,  
Rivadávio Fernandes Batista Amorim3, Maria Alice de Vilhena Toledo4
ABSTRACT. Patients with Bipolar Disorder (BD) usually display cognitive deficits with aging. However, the correlation 
between BD and dementia syndromes is inconclusive, despite the similarity with behavioral variant frontotemporal 
dementia. We report a 78-year-old female patient who had bipolar type 1 disorder since adolescence. Her symptoms 
ranged from apathy to psychotic mania. She had had three hospitalizations, and since her last stay 10 years ago, her 
symptoms had remained stable. However, in the past 2 years, she displayed different symptoms, such as irritability 
manifested as verbal and physical aggression, cognitive impairment, repetitive pattern of behavior, perambulation, 
persecutory delusions, disorientation, and hyporexia. Treatment with anticholinesterases or mood stabilizers promoted 
no improvement. She scored 17/30 points on the Mini-Mental State Examination. Neuropsychological assessment 
suggested deficits in executive function, attention, and memory. Neuroimaging tests revealed frontotemporal degeneration 
and hypoperfusion. Diagnostic and therapeutic approaches for this type of patient represent a significant challenge for 
clinicians.
Key words: bipolar disorder, frontotemporal dementia, geriatric neuropsychiatry, neuroprogression.
COMPROMETIMENTO COGNITIVO NO TRANSTORNO BIPOLAR: NEUROPROGRESSÃO OU VARIANTE COMPORTAMENTAL DA 
DEMÊNCIA FRONTOTEMPORAL?
RESUMO. Pacientes com Transtorno Bipolar (TB) costumam apresentar déficits cognitivos ao envelhecer. No entanto, 
a correlação com síndromes demenciais é inconclusiva, apesar da similaridade com a variante comportamental 
da demência frontotemporal (bvFTD). Nós relatamos uma paciente de 78 anos de idade com TB tipo 1 desde a 
adolescência. Seus sintomas variavam de apatia a mania psicótica. A paciente passou por 3 internações, sendo 
a última há 10 anos, seguida de estabilização clínica. No entanto, nos últimos 2 anos, ela apresentou sintomas 
diferentes, como irritabilidade expressada por agressões verbal e física, comprometimento cognitivo, padrão repetitivo de 
comportamento, perambulação, delírios persecutórios, desorientação e hiporexia. O tratamento com anticolinesterásicos 
ou estabilizadores de humor não revelou melhora. Apresentou 17/30 pontos no miniexame do estado mental, a avaliação 
neuropsicológica sugeriu déficit de função executiva, atenção e memória. Os exames de neuroimagem demonstraram 
atrofia e hipoperfusão fronto-temporal. Abordagens diagnósticas e terapêuticas para este tipo de paciente representam 
um desafio significativo para os clínicos.
Key words: transtorno bipolar, demência frontotemporal, neuropsiquiatria geriátrica, neuroprogressão.
Cognitive impairment has a close rela-tionship with mental disorders. In this 
scenario, Bipolar Disorder (BD) presents the 
highest risk for the development of demen-
tia syndromes when compared to other clini-
cal diseases.1 Cognitive impairments in the 
course of BD affect mainly memory, atten-
tion, language, and executive functions, even 
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during the euthymia stage.2 Despite the similarities with 
behavioral variant frontotemporal dementia (bvFTD), 
attempts to correlate BD with dementia syndromes have 
proved inconclusive.3 Although some studies reveal sta-
bility of cognitive impairment,4 others show cognitive 
impairment and neuroprogression to dementia.5
It is worth mentioning that doubts concerning the 
differentiation between the cognitive impairment typi-
cal in older patients with bipolar I disorder (BDI) and 
that seen in other dementias pose diagnostic challenges 
and can lead to treatment failures. For instance, the use 
of anticholinesterasics in patients with BDI may not be 
appropriate, with some cases of manic-switch reported.6 
In this context, the present study aims to describe the 
observations of a patient who clearly displayed neuro-
psychiatric symptoms and the possibility of neuropro-
gression in BDI. Based on this report, we intend to draw 
neuropsychological inferences and demonstrate the 
need for a better understanding on evolution of bipolar 
patients. 
CASE REPORT
A 78-year-old woman was admitted to a university clinic 
with complaints of cognitive impairment associated 
with functional deterioration and worsening behavior. 
At admission, she was totally dependent according to 
the Lawton Instrumental Activities of Daily Living Scale 
(IADLs) (0/9 points)7 and semi-dependent according 
to the Katz index of independence in Activities of 
Daily Living (Katz ADL) (4/6),8 requiring assistance for 
bathing and tooth brushing. The patient had received 4 
years of education and was diagnosed with BDI at age 
16. She had been given galantamine 16  mg/day because 
of suspected Alzheimer’s disease (AD). Despite the 
treatment, the patient displayed worsening hyporexia, 
psychomotor agitation, and no clinically significant 
improvements in cognition, behavior, or functioning. 
She had had three hospitalizations and the symp-
toms ranged from apathy to euphoria with psychotic 
symptoms. The last hospitalization occurred 10 years 
before referral. After hospital discharge, the patient 
Figure 1. [A] Magnetic Resonance Imaging (MRI)* [B] Magnetic Resonance Imaging (MRI)**.
*Axial Flair Brain MRI shows cortical atrophy with frontotemporal predominance and abnormal signal intensity in  
white matter suggestive of incipient ischemic microangiopathy. **Coronary slices show global atrophy with hippocampal atrophy.
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remained in euthymia for 6 years and was treated with 
oxcarbazepine at a dose of 600 mg/day, bromazepam 3 
mg/day, and risperidone 1 mg/day. However, the patient 
reported progressive neuropsychiatric alterations in the 
last 2 years with different characteristics, such as impul-
sivity and irritability manifesting as verbal and physical 
aggression, short-term memory loss, repetitive pattern 
of behavior, perambulation, persecutory delusions, 
disorientation, and hyporexia. She also presented with 
occupational impairment and loss of functionality, forc-
ing her to take leave from her work activities.
Neuropsychological evaluation revealed executive 
function, language, memory and attention deficits, 
with considerable frontal lobe involvement (Table 1). In 
her recent neuroimaging studies, magnetic resonance 
imaging (MRI) of the brain showed brain atrophy with 
frontotemporal predominance and incipient ischemic 
microangiopathy (Figure 1). Single-photon emission 
computed tomography (SPECT) revealed moderate-to-
severe bilateral frontotemporal hypoperfusion/activa-
tion (Figure 2) The patient had a long history of medi-


























































IQ General IQ   
Attention and Executive Function
Auditory/verbal attention amplitude  
Auditory/verbal working memory  
Copy of alternating drawings  
Visuo-Spatial Organization
Copy of simple geometric stimulus    
Drawing of simple figures    
Clock drawing  
Perspective figure copy  
Language
Semantic verbal fluency  
Naming by visual confrontation   
Understanding simple verbal commands  
Abstract verbal thinking  
Visual Functions Visual gnosis    






Immediate verbal episodic memory  
Delayed verbal episodic memory  
Cued verbal learning  
Verbal learning - delayed recall  
Verbal recognition (Errors = 8)  
Associative memory  
Visual Immediate visual memory  
Delayed visual memory  
Table 1. Neuropsychological test results.
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Figure 2. Single-Photon Emission Computed Tomography (SPECT). 
Image showing moderate-to-severe hypoperfusion/hypoactivation in regions of the bilateral frontal and temporal cortices.
valproate, olanzapine, sertraline, escitalopram, and 
trazodone. She presented with systemic arterial hyper-
tension and hypothyroidism. She reported no history of 
alcoholism, smoking, or illicit drug use. Two sisters had 
psychiatric disorders and the mother had an unspecified 
dementia syndrome.
Clinical examination revealed signs of parkinsonism, 
aggressiveness, apathy, speech impairment, depressed 
mood, and facial hypomimia. On cognitive assessment, 
the patient scored 17/30 points in the Mini-Mental 
State Examination (MMSE) and 5 points in the verbal 
fluency test using the animal category. Laboratory and 
serology tests for secondary dementia screening were all 
within the normal range. In addition, the diagnosis of 
delirium was excluded based on complementary exams 
and also considering that the disease is characterized by 
acute symptoms with fluctuating clinical course.
In this context, we hypothesized the presence of 
a non-Alzheimer’s dementia syndrome with possible 
bvFTD or cognitive impairment as a result of neuro-
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progression in BDI. We opted to suspend galantamine, 
withdraw risperidone and continue with quetiapine. 
Although the patient progressed with partial improve-
ment of psychomotor agitation, she showed gradual 
worsening of apathy and aphasia, with progressive cog-
nitive/functional losses. The patient died 4 years later 
from pulmonary infectious complications.
DISCUSSION
Although our patient revealed a profile and clinical 
evolution similar to those described in neuropro-
gression in BD,9 the association with other dementia 
syndromes, especially bvFTD, could not be excluded. 
A systematic review describing cognitive impairment 
in bipolar patients has been published, especially 
addressing executive function disorder.10 It suggested 
that bipolar patients have a reduced cerebral reserve 
capacity, demonstrated by worsening cognitive impair-
ment throughout the lifespan.10  The type of cogni-
tive impairment observed in BD patients may have a 
clinical, neuropsychological and imaging presentation 
that resembles bvFTD.11 Clinical observations report 
neuroprogression to dementia in patients with BD over 
a 30-year period.12 Some recent studies have suggested 
an etiopathogenic association between BD and a 
specific dementia syndrome, similar to bvFTD.12
In the present case, we observed a change in our 
patient’s patterns of behavior when compared to the 
symptoms previously presented, but occurring at a later 
age. These changes failed to respond adequately to the 
use of mood stabilizers or anticholinesterasics, evolv-
ing with behavioral worsening, and progressive cogni-
tive and functional impairment. Based on the current 
diagnostic criteria for bvFTD,13 and on evidence showing 
that age has little influence on manic psychopathology,14 
it is possible to affirm that our patient had probable 
bvFTD, although we understand that BD could cause 
underlying cognitive impairments. Even though bipo-
lar patients have an increased risk of cognitive impair-
ment associated with age-related pathologies,1 atypical 
Alzheimer’s dementia was not considered as a differ-
ential diagnosis based on initial behavioral worsening, 
therapeutic response and neuroimaging findings. 
The literature shows impact on the psychosocial 
functioning of these patients mainly due to mood state 
and cognition, which may remain even after the acute 
phases of the disease.2 
Factors linked to BD that may influence cognition 
include number of mood or psychotic episodes, hospital-
izations, age at onset, duration of illness, polypharmacy, 
and presence of clinical comorbidity.10 Our patient had 
a long history of BDI, with past psychiatric hospitaliza-
tions, psychotic symptoms, and use of various psycho-
tropic medications.
Elderly patients with BD had worse performance on 
psychomotor speed, attention, memory, verbal fluency, 
and executive functions, as well as worse psychosocial 
functioning, independent of current mood state or iat-
rogenic effects of psychotropic drugs.15,16 Neuropsycho-
logical assessment suggested an impairment pattern 
that could be present both in patients with BDI and 
dementia syndromes.2 Thus, establishing a differential 
diagnosis of bvFTD in a bipolar patient becomes a chal-
lenge, and we could not rule out a causal association 
between the two entities.
There is weak evidence that cortical atrophy and 
white-matter vascular lesions are more common in 
older people with BD than in normal controls, where 
it remains uncertain whether this finding is attributed 
to the psychopathological process or to secondary fac-
tors.17 We performed neuroimaging analysis to evaluate 
the differential diagnosis considering that the patient 
exhibited behavioral and cognitive changes suggestive 
of bvFTD. In our patient, functional and structural neu-
roimaging studies revealed signs of hypofunction and 
atrophy of the frontotemporal region, as demonstrated 
in scientific literature establishing a possible asso-
ciation between frontal and temporal circuit dysfunc-
tion and certain cognitive impairments.18 A follow-up 
study established an association between BDI severity, 
memory loss, and reduction of gray matter volume in 
the medial temporal cortex.19 This information may 
be strongly associated with frontal and social deficits 
exhibited by individuals with BD. The vascular hypoth-
esis for the impairments found in our patient would be 
less likely given the minor subcortical vascular damage 
observed, relatively common in patients from this age 
group.20
Although signs of memory deficits have been 
reported as commencing together with the patient’s 
functional decline, disagreement between the onset of 
objective memory impairments and the observation of 
the symptoms by third-parties is not uncommon, usu-
ally because these individuals are unaware of dementia 
syndromes. A possible hypothesis could be the mistaken 
notion that memory loss and functional decline are an 
inevitable part of aging or a refusal to accept a decline 
in the functional abilities of relatives with dementia.21 
Although memory is only affected in more advanced 
stages of FTD, the initial picture of apathy, irritabil-
ity, and impairment in self-control, self-care, and body 
hygiene revealed by our patient fits into the clinical 
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manifestations typical of FTD patients. In the case of 
FTD, behavioral changes tend to be more prominent in 
the early stages, with preservation of visuospatial func-
tions, spatial orientation, and memory, contrasting with 
milder changes in behavior, less self-neglect and emo-
tional blunting, and a longer course related to a possible 
distinct dementia in BD.13,22
The concept of clinical heterogeneity is present in 
both pathologies, representing a difficulty in establish-
ing precise diagnostic criteria, particularly in bvFTD, 
whose criteria have been the subject of discussion and 
proposals for revision due to the expansion of the func-
tional, genetic, and biochemical knowledge.23 Hypoth-
eses related to neuroprogression and neurodegenera-
tion may justify the cognitive impairments presented 
by patients with BD, probably due to a combination of 
early genetic factors, environmental risk factors, medi-
cal comorbidities, iatrogenic effects, and aging itself.23,24 
Glial cell density reductions demonstrated in postmor-
tem studies in patients with BD reveal that their brains 
may be more vulnerable to toxic, metabolic, and isch-
emic insults during adult life.25
In view of the information presented here, it is per-
tinent to infer the need for further prospective studies, 
especially cohort studies associated with postmortem 
pathological analysis involving patients with BDI, to bet-
ter clarify the biological plausibility of cognitive impair-
ment, which might be a multifactorial entity with differ-
ent evolution patterns from those observed in bvFTD. 
Another important aspect is the establishment of new 
protocols for neuropsychological assessment and of 
nosological classification criteria with the use of neuro-
imaging for diagnostic elucidation.
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